Europe Missed Antimicrobial Resistance Targets
The region is projected to fall short on four of its five goals for 2030 to curb resistant infections.
Updated on Sept. 30, 2026 in COVID-19
Live Poll
Should national governments implement stricter regulations to curb the overuse of antibiotics?
Europe is expected to fail on four of its five key antimicrobial resistance targets by 2030. The region continues to struggle as more than 35,000 people die annually from antibiotic-resistant infections.
Why it matters
The persistent emergence of resistant germs is driven by the ongoing misuse and overuse of antibiotics. Failure to meet these reduction goals threatens to exacerbate public health challenges across the continent.
Antibiotic consumption in 2024 was 2% higher than in 2019, despite an established EU government mandate to reduce human consumption by 20%. Experts project that Europe will fail to achieve four out of its five established 2030 resistance benchmarks.
The players
European Partnership on One Health AMR
This is a collaborative network comprising over 50 organizations focused on addressing the threat of antimicrobial resistance.
The details
The European Partnership on One Health AMR, which includes over 50 organizations, is currently working to manage the crisis. Regulatory efforts include the EU pharmaceutical package, which utilizes transferable data exclusivity vouchers to incentivize the development of new antimicrobials.
Timeline
2019 served as the baseline year for EU antibiotic consumption reduction targets.
EU governments set formal targets to reduce antibiotic consumption in 2023.
Antibiotic consumption levels were measured throughout 2024.
The deadline for achieving European antimicrobial resistance targets is 2030.
Deeper Dive
This situation updates figures previously established by the EU pharmaceutical package. While the policy provides mechanisms for new drug development, these findings indicate it is currently insufficient to meet regional health benchmarks.
Rising antibiotic resistance limits the effectiveness of common medical treatments for the average person. Patients may face longer recovery times and fewer successful therapeutic options for routine bacterial infections.
The takeaway
Healthcare providers and patients must prioritize the judicious use of antibiotics to preserve their efficacy for future needs. Continued reliance on existing consumption patterns poses a significant risk to long-term community health outcomes.
Further reading
Learn more about the latest developments in COVID-19 research and public health surveillance.
Source note: This article includes information reported by Euractiv DE.
Live Poll
Should national governments implement stricter regulations to curb the overuse of antibiotics?
